Related Experiment Videos
Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue
Thijs van Dalen1, Adriaan Hennipman, Frits Van Coevorden
1Dutch Soft Tissue Sarcoma Group, Vereniging van Integrale Kanker Centra, Utrecht, The Netherlands.
Annals of Surgical Oncology
|April 14, 2004
Summary
A new postsurgical classification system for retroperitoneal sarcoma improves prognosis prediction. Treatment at high-volume centers offers better survival for low-grade, completely resected soft-tissue sarcoma.
Area of Science:
- Oncology
- Surgical Pathology
- Sarcoma Research
Background:
- Current AJCC/TNM staging for retroperitoneal sarcoma has limited prognostic value.
- A need exists for a postsurgical classification system to compare outcomes in primary retroperitoneal soft-tissue sarcoma patients.
Purpose of the Study:
- To develop and validate a postsurgical classification system for primary retroperitoneal soft-tissue sarcoma.
- To assess the prognostic capability of the new classification system.
Main Methods:
- A four-class system was defined based on grade, resection completeness, and metastasis.
- Prognostic value was analyzed in a multicenter group (MCG, n=124) and a single center group (SCG, n=107).
Main Results:
- Overall 5-year survival was higher in the SCG (55%) than the MCG (43%).
- Incomplete resection (Class III) was more frequent in the MCG.
- Stage-specific survival rates varied significantly by class within each group, with SCG Class I patients showing better survival.
Conclusions:
- The developed classification system (grade, resection, metastasis) is a reproducible prognostic tool for retroperitoneal soft-tissue sarcoma.
- Complete resection rates were higher in the SCG.
- Low-grade, completely resected sarcoma patients benefit significantly from treatment at high-volume centers.